Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 12-2017 | |
Operating Expenses | 69,318 | 63,752 | 0 | 41,456 | 0 |
Operating Income | -69,318 | -63,752 | N/A | -41,456 | N/A |
Interest Expense | 1,941 | 1,671 | 0 | 1,156 | 0 |
Other Income | -3,075 | -4,013 | 0 | 534 | 0 |
Pre-tax Income | -74,334 | -69,436 | 0 | -42,078 | 0 |
Net Income Continuous | -74,334 | -69,436 | N/A | -42,078 | N/A |
Minority Interests | -8,370 | -8,251 | N/A | -10,677 | N/A |
Net Income | $-65,964 | $-61,185 | $N/A | $-31,401 | $N/A |
EPS Basic Total Ops | -0.71 | -0.66 | N/A | -0.52 | N/A |
EPS Basic Continuous Ops | -0.80 | -0.75 | N/A | -0.69 | N/A |
EPS Diluted Total Ops | -0.71 | -0.66 | N/A | -0.52 | N/A |
EPS Diluted Continuous Ops | -0.80 | -0.75 | N/A | -0.69 | N/A |
EBITDA(a) | $-69,318 | $-63,752 | $N/A | $-41,456 | $N/A |